Synopsys, Inc. $SNPS Shares Acquired by Kestra Advisory Services LLC

Kestra Advisory Services LLC lifted its position in shares of Synopsys, Inc. (NASDAQ:SNPS) by 35.8% in the third quarter, according to its most recent 13F filing with the SEC. The firm owned 7,295 shares of the semiconductor company’s stock after purchasing an additional 1,923 shares during the quarter. Kestra Advisory Services LLC’s holdings in Synopsys were worth $3,173,000 as of its most recent filing with the SEC.

A number of other institutional investors and hedge funds have also recently bought and sold shares of the business. Elevation Wealth Partners LLC lifted its position in Synopsys by 96.4% during the second quarter. Elevation Wealth Partners LLC now owns 55 shares of the semiconductor company’s stock valued at $25,000 after buying an additional 27 shares in the last quarter. North Dakota State Investment Board grew its stake in Synopsys by 0.5% during the third quarter. North Dakota State Investment Board now owns 5,706 shares of the semiconductor company’s stock worth $2,482,000 after buying an additional 29 shares during the period. Oak Grove Capital LLC increased its position in shares of Synopsys by 1.1% in the third quarter. Oak Grove Capital LLC now owns 2,898 shares of the semiconductor company’s stock worth $1,260,000 after acquiring an additional 32 shares in the last quarter. Kintegral Advisory LLC increased its position in shares of Synopsys by 0.6% in the third quarter. Kintegral Advisory LLC now owns 5,812 shares of the semiconductor company’s stock worth $2,528,000 after acquiring an additional 32 shares in the last quarter. Finally, Centaurus Financial Inc. increased its position in shares of Synopsys by 2.6% in the first quarter. Centaurus Financial Inc. now owns 1,434 shares of the semiconductor company’s stock worth $569,000 after acquiring an additional 36 shares in the last quarter. Institutional investors and hedge funds own 85.47% of the company’s stock.

Wall Street Analyst Weigh In

SNPS has been the topic of a number of research reports. Rothschild & Co Redburn cut their target price on shares of Synopsys from $560.00 to $550.00 and set a “buy” rating on the stock in a research note on Wednesday, September 23rd. Morgan Stanley upped their price target on shares of Synopsys from $500.00 to $574.00 and gave the stock an “overweight” rating in a research report on Tuesday, October 20th. Benchmark reiterated a “buy” rating and issued a $570.00 price target on shares of Synopsys in a report on Thursday, August 27th. Barclays started coverage on Synopsys in a report on Friday, September 25th. They issued an “overweight” rating for the company. Finally, Deutsche Bank reissued a “buy” rating and issued a $640.00 price objective (up from $590.00) on shares of Synopsys in a research report on Thursday, October 1st. One investment analyst has rated the stock with a Strong Buy rating, twenty-two have given a Buy rating and three have assigned a Hold rating to the company. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $575.00.

Insider Activity

In other Synopsys news, insider Janet Lee sold 1,144 shares of the company’s stock in a transaction dated Tuesday, October 6th. The shares were sold at an average price of $502.52, for a total value of $574,882.88. Following the completion of the transaction, the insider directly owned 16,534 shares of the company’s stock, valued at $8,308,665.68. This represents a 6.47% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Also, CEO Sassine Ghazi sold 14,604 shares of the company’s stock in a transaction dated Thursday, October 15th. The shares were sold at an average price of $462.84, for a total transaction of $6,759,315.36. Following the completion of the transaction, the chief executive officer directly owned 76,865 shares of the company’s stock, valued at approximately $35,576,196.60. The trade was a 15.97% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last quarter, insiders sold 117,163 shares of company stock worth $51,366,457. Corporate insiders own 0.56% of the company’s stock.

Synopsys Stock Down 1.6%

Shares of SNPS traded down $7.49 during mid-day trading on Friday, reaching $455.20. 2,005,399 shares of the stock traded hands, compared to its average volume of 1,947,810. The firm has a market cap of $87.23 billion, a price-to-earnings ratio of 80.42, a P/E/G ratio of 1.47 and a beta of 1.18. The stock has a fifty day simple moving average of $445.16 and a 200 day simple moving average of $441.11. Synopsys, Inc. has a 12-month low of $362.55 and a 12-month high of $539.48. The company has a quick ratio of 1.24, a current ratio of 1.34 and a debt-to-equity ratio of 0.29.

Synopsys (NASDAQ:SNPS) last posted its earnings results on Wednesday, August 26th. The semiconductor company reported $3.91 EPS for the quarter, topping analysts’ consensus estimates of $3.67 by $0.24. The business had revenue of $2.48 billion for the quarter, compared to analysts’ expectations of $2.44 billion. Synopsys had a net margin of 11.43% and a return on equity of 6.24%. The business’s revenue for the quarter was up 42.4% compared to the same quarter last year. During the same period in the previous year, the company posted $3.39 earnings per share. Synopsys has set its Q4 2026 guidance at 4.100-4.160 EPS and its FY 2026 guidance at 15.040-15.100 EPS. Sell-side analysts expect that Synopsys, Inc. will post 11.01 EPS for the current fiscal year.

Synopsys declared that its Board of Directors has approved a share repurchase plan on Monday, October 5th that allows the company to repurchase $1 billion in outstanding shares. This repurchase authorization allows the semiconductor company to repurchase up to 1.1% of its shares through open market purchases. Share repurchase plans are generally an indication that the company’s board of directors believes its stock is undervalued.

Synopsys News Summary

Investors following SNPS have been watching these news items:

• Positive Sentiment: Coverage points to AI-powered chip design and verification, expanding EDA capabilities and the Ansys integration as potential growth drivers. A Seeking Alpha article also argues Synopsys could exceed growth estimates. Can AI-Driven EDA Accelerate Synopsys’ Next Growth Phase? Synopsys Looks Poised To Outperform Growth Estimates
• Neutral Sentiment: An investment outlook notes Synopsys’ growth drivers alongside export-control risks, leaving the longer-term case dependent on both demand and regulation. If You Invest $1,000 in Synopsys Today, Here’s What It Could Be Worth by 2029
• Negative Sentiment: ETFs were reported as net sellers of Synopsys shares, disposing of $10.1 million on Nov. 11—a potential source of near-term selling pressure. ETFs Are Net Sellers of Synopsys

About Synopsys

Synopsys, Inc. develops software, semiconductor intellectual property (IP) and services used to design and verify electronic systems. Its electronic design automation (EDA) tools help customers create, simulate, test and validate chips and other complex electronic products, while its IP portfolio provides reusable building blocks for semiconductor designs. The company also offers software security and quality tools that help developers identify vulnerabilities and assess applications throughout the software development process.